Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Organizations issue five-point plan to accelerate research, discovery of effective prostate cancer treatments

Organizations issue five-point plan to accelerate research, discovery of effective prostate cancer treatments

TNS NIPO study underlines need for wide-scale, reliable prostate cancer screening

TNS NIPO study underlines need for wide-scale, reliable prostate cancer screening

Harbor BioSciences releases Apoptone clinical trial data for castration resistant prostate cancer

Harbor BioSciences releases Apoptone clinical trial data for castration resistant prostate cancer

Researchers develop new blood test to predict prostate cancer risk

Researchers develop new blood test to predict prostate cancer risk

Progenics Pharmaceuticals presents findings of humanized monoclonal antibodies against C. difficile bacterium

Progenics Pharmaceuticals presents findings of humanized monoclonal antibodies against C. difficile bacterium

Men with low PSA level does not benefit further treatment: Study

Men with low PSA level does not benefit further treatment: Study

Measuring PSA levels effective in detecting  prostate cancer: Study

Measuring PSA levels effective in detecting prostate cancer: Study

PCRI to host educational event on prostate cancer therapy

PCRI to host educational event on prostate cancer therapy

Pennsylvania Bio issues new report on Pennsylvania's bioscience companies' efforts for cancer research

Pennsylvania Bio issues new report on Pennsylvania's bioscience companies' efforts for cancer research

Ortho Biotech unblinded abiraterone acetate Phase 3 study for prostate cancer patients

Ortho Biotech unblinded abiraterone acetate Phase 3 study for prostate cancer patients

Nucletron to present innovative cancer treatment during ESTRO29

Nucletron to present innovative cancer treatment during ESTRO29

Experts advise men to maintain record of prostate specific antigen test results for risk detection

Experts advise men to maintain record of prostate specific antigen test results for risk detection

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Non-invasive test using patient's breath can detect cancer

Non-invasive test using patient's breath can detect cancer

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

Progenics commences Phase 3 trial of oral methylnaltrexone for opioid-induced constipation

Progenics commences Phase 3 trial of oral methylnaltrexone for opioid-induced constipation

AHRQ releases free evidence-based guides for eight health conditions

AHRQ releases free evidence-based guides for eight health conditions

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

Protagen AG announces € 10.0 Million for second round of finance totaling

Protagen AG announces € 10.0 Million for second round of finance totaling

CyberKnife radiosurgery treatment effective for prostate cancer without side effects

CyberKnife radiosurgery treatment effective for prostate cancer without side effects

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.